From Surf Wiki (app.surf) — the open knowledge base
Talaporfin
Chemical compound
Chemical compound
| Drugs.com =
| elimination_half-life =
(sodium salt)
Talaporfin (INN, also known as aspartyl chlorin, mono-L-aspartyl chlorin e6, NPe6, or LS11) is a chlorin based photosensitizer used in photodynamic therapy (PDT).
It absorbs red light at 664-667 nm normally provided by a laser tuned to this wavelength.
It was approved in Japan (in 2004) for PDT of lung cancer and marketed as Laserphyrin.
References
Extracorporeal Photo-Immunotherapy for Circulating Tumor Cells
References
- (June 2006). "Photodynamic therapy (PDT) for lung cancers". Journal of Thoracic Oncology.
- (June 2006). "Photodynamic therapy using Laserphyrin for centrally located early stage lung cancer.". Journal of Clinical Oncology.
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about Talaporfin — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report